Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…
Browsing: WCLC
Comprehensive genomic profiling aids in the identification of personalised therapeutic options
Findings from a recent study demonstrate that comprehensive genetic profiling (CGP) is a useful tool…
Survey data from Lung Cancer Alliance highlights the unmet emotional needs of long-term lung cancer survivors
A recent survey found lung cancer survivors indicate that emotional effects, unlike physical impacts, are…
Study shows women with non-small cell lung cancers live longer than men
Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their male counterparts, according…
Atezolizumab combination improves PFS for advanced NSCLC patients
Findings from a recent study demonstrate that the use of atezolizumab, a PD-L1 inhibitor, in…
Promising phase 1/2 results for entrectinib against ROS1 non-small cell lung cancer
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive…
Outdoor air pollution exposure significantly higher in women non-smokers with lung cancer than women smokers with lung cancer
Findings from a recent study demonstrate that female lung cancer patients who have never smoked…